CRP and Parkinson disease: C-reactive protein (CRP), a very sensitive and important inflammatory mediator, was been shown to be a valid predictor of new cardiovascular risks, type 2 diabetes, ischemic cerebrovascular disease, and PD (Fu et al., 2009; Song et al., 2009).